4
Changes in Ownership
Benitec Biopharma Inc. Filed Acc 0001062993-24-020464
Options or other derivatives
- Chief Executive Officer acquired 2,310,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Banks Jerel A. Chief Executive Officer | 2024-12-09 | Grant or award · Options (right to buy) | +2,310,000 | 2,310,000 | D | ||
Loading xslF345X05/form4.xml…